$0.814000
-0.02-2.78%
At close: -
$0.810000
-0.0040-0.49%
After Hours: Nov 15, 7:38 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Karyopharm Therapeutics in recent months.
Browse guidance and forecast on all stocks.